The risk of re-identification versus the need to identify individuals in rare disease research

M.G. Hansson, H. Lochmüller, O. Riess, F. Schaefer, M. Orth, Y. Rubinstein, C. Molster, Hugh Dawkins, D. Taruscio, M. Posada, S. Woods

    Research output: Contribution to journalArticle

    16 Citations (Scopus)

    Abstract

    © 2016 Macmillan Publishers Limited, part of Springer Nature.
    There is a growing concern in the ethics literature and among policy makers that de-identification or coding of personal data and biospecimens is not sufficient for protecting research subjects from privacy invasions and possible breaches of confidentiality due to the possibility of unauthorized re-identification. At the same time, there is a need in medical science to be able to identify individual patients. In particular for rare disease research there is a special and well-documented need for research collaboration so that data and biosamples from multiple independent studies can be shared across borders. In this article, we identify the needs and arguments related to de-identification and re-identification of patients and research subjects and suggest how the different needs may be balanced within a framework of using unique encrypted identifiers.
    Original languageEnglish
    Pages (from-to)1553-1558
    JournalEuropean Journal of Human Genetics
    Volume24
    Issue number11
    Early online date25 May 2016
    DOIs
    Publication statusPublished - Nov 2016

    Fingerprint

    Research Subjects
    Rare Diseases
    Privacy
    Confidentiality
    Administrative Personnel
    Research
    Ethics

    Cite this

    Hansson, M. G., Lochmüller, H., Riess, O., Schaefer, F., Orth, M., Rubinstein, Y., ... Woods, S. (2016). The risk of re-identification versus the need to identify individuals in rare disease research. European Journal of Human Genetics, 24(11), 1553-1558. https://doi.org/10.1038/ejhg.2016.52
    Hansson, M.G. ; Lochmüller, H. ; Riess, O. ; Schaefer, F. ; Orth, M. ; Rubinstein, Y. ; Molster, C. ; Dawkins, Hugh ; Taruscio, D. ; Posada, M. ; Woods, S. / The risk of re-identification versus the need to identify individuals in rare disease research. In: European Journal of Human Genetics. 2016 ; Vol. 24, No. 11. pp. 1553-1558.
    @article{9b833330b39f4370aa1c5d92a779db40,
    title = "The risk of re-identification versus the need to identify individuals in rare disease research",
    abstract = "{\circledC} 2016 Macmillan Publishers Limited, part of Springer Nature. There is a growing concern in the ethics literature and among policy makers that de-identification or coding of personal data and biospecimens is not sufficient for protecting research subjects from privacy invasions and possible breaches of confidentiality due to the possibility of unauthorized re-identification. At the same time, there is a need in medical science to be able to identify individual patients. In particular for rare disease research there is a special and well-documented need for research collaboration so that data and biosamples from multiple independent studies can be shared across borders. In this article, we identify the needs and arguments related to de-identification and re-identification of patients and research subjects and suggest how the different needs may be balanced within a framework of using unique encrypted identifiers.",
    author = "M.G. Hansson and H. Lochm{\"u}ller and O. Riess and F. Schaefer and M. Orth and Y. Rubinstein and C. Molster and Hugh Dawkins and D. Taruscio and M. Posada and S. Woods",
    year = "2016",
    month = "11",
    doi = "10.1038/ejhg.2016.52",
    language = "English",
    volume = "24",
    pages = "1553--1558",
    journal = "European Journal of Human Genetics",
    issn = "1018-4813",
    publisher = "Nature Publishing Group - Macmillan Publishers",
    number = "11",

    }

    Hansson, MG, Lochmüller, H, Riess, O, Schaefer, F, Orth, M, Rubinstein, Y, Molster, C, Dawkins, H, Taruscio, D, Posada, M & Woods, S 2016, 'The risk of re-identification versus the need to identify individuals in rare disease research' European Journal of Human Genetics, vol. 24, no. 11, pp. 1553-1558. https://doi.org/10.1038/ejhg.2016.52

    The risk of re-identification versus the need to identify individuals in rare disease research. / Hansson, M.G.; Lochmüller, H.; Riess, O.; Schaefer, F.; Orth, M.; Rubinstein, Y.; Molster, C.; Dawkins, Hugh; Taruscio, D.; Posada, M.; Woods, S.

    In: European Journal of Human Genetics, Vol. 24, No. 11, 11.2016, p. 1553-1558.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The risk of re-identification versus the need to identify individuals in rare disease research

    AU - Hansson, M.G.

    AU - Lochmüller, H.

    AU - Riess, O.

    AU - Schaefer, F.

    AU - Orth, M.

    AU - Rubinstein, Y.

    AU - Molster, C.

    AU - Dawkins, Hugh

    AU - Taruscio, D.

    AU - Posada, M.

    AU - Woods, S.

    PY - 2016/11

    Y1 - 2016/11

    N2 - © 2016 Macmillan Publishers Limited, part of Springer Nature. There is a growing concern in the ethics literature and among policy makers that de-identification or coding of personal data and biospecimens is not sufficient for protecting research subjects from privacy invasions and possible breaches of confidentiality due to the possibility of unauthorized re-identification. At the same time, there is a need in medical science to be able to identify individual patients. In particular for rare disease research there is a special and well-documented need for research collaboration so that data and biosamples from multiple independent studies can be shared across borders. In this article, we identify the needs and arguments related to de-identification and re-identification of patients and research subjects and suggest how the different needs may be balanced within a framework of using unique encrypted identifiers.

    AB - © 2016 Macmillan Publishers Limited, part of Springer Nature. There is a growing concern in the ethics literature and among policy makers that de-identification or coding of personal data and biospecimens is not sufficient for protecting research subjects from privacy invasions and possible breaches of confidentiality due to the possibility of unauthorized re-identification. At the same time, there is a need in medical science to be able to identify individual patients. In particular for rare disease research there is a special and well-documented need for research collaboration so that data and biosamples from multiple independent studies can be shared across borders. In this article, we identify the needs and arguments related to de-identification and re-identification of patients and research subjects and suggest how the different needs may be balanced within a framework of using unique encrypted identifiers.

    U2 - 10.1038/ejhg.2016.52

    DO - 10.1038/ejhg.2016.52

    M3 - Article

    VL - 24

    SP - 1553

    EP - 1558

    JO - European Journal of Human Genetics

    JF - European Journal of Human Genetics

    SN - 1018-4813

    IS - 11

    ER -